Development of experimental alloxan model of diabetes mellitus

Abstract

Background. One of the main causes that lead to the disability of diabetic patients is diabetic retinopathy (DR). The relevance of the problem of DR necessitates the development of optimal experimental models on experimental animals to find effective ways of correcting this pathology. The purpose of our work was to develop an experimental alloxan model of type 1 diabetes mellitus (DM) for the study of DR, which would not result in the lethal outcome of experimental animals under the action of alloxan; histological examination of changes in the tissues of the eyeball in the reproduction of the DM model for the selection of new effective methods for the metabolic treatment of DR in the early stages. Materials and methods. The experiment was carried out on white outbred Wistar rats weighing 180–200 g. The first group consisted of 20 animals that were not subjected to any influence, served as a control; second group — 30 animals, in which DM was modeled by administration of alloxan and fructose. Results. When modeling DR, vessel changes in the form of wall fibrosis, edema of the endothelium and vasospasm were found. There was also a decrease in the amount of pigment granules, dystrophic changes in the cells of the ganglionic layer and a layer of retinal rods and cones, which coincides with the descriptions of damage to the coats of the eyeball in patients with DM. Conclusions. In our studies, we have calculated the optimal dose of alloxan administration, which does not lead to the death of rats (the lethality of rats was absent) and is an effective model not only of DM in general, but also of DR.

Authors and Affiliations

V. V. Semenko, V. M. Serdyuk, I. V. Savytskyi

Keywords

Related Articles

The Disorders of Growth Hormone Secretion in Women with Polycystic Ovary Syndrome Compared to Patients with the Non-Functional Pituitary Adenomas

Objective of the study — ​to investigate the disorders of growth hormone (GH) secretion in women with polycystic ovary syndrome (PCOS) compared to patients with non-functional pituitary adenomas (NFPA). Under our supervi...

Clinical efficiency of aerobic exercises in the young patients with type 1 diabetes mellitus

Background. The purpose of the study is to investigate the effect of regular aerobic physical exercises with 6-point intensity by Borg scale on glycemic profile, insulin sensitivity, and quality of life of patients with...

Indicators of endothelial dysfunction in type 2 diabetes mellitus as factors for the development of complications

Background. To determine the pathogenetic role of the main factors reflecting the development of endothelial dysfunction (EDF), an attempt was made within the framework of one study to calculate their effect on the occur...

Clinical and Morphological Description of Cardiovascular System and Medical and Social Rehabilitation of Diabetic Patients

The study described in the paper was aimed to investigate cardiovascular system functioning in diabetic patients. The impairments of systolic and diastolic myocardial functions combined with different types of left ventr...

Diazide MR — New Gliclazide with Modified Release and Once Daily Dosing (Literature Review)

This review deals with features of using gliclazide MR, in particular Diabeton MR and Diazide MR, in the treatment of patients with diabetes mellitus type 2. There is provided a detailed description of some gliclazide pr...

Download PDF file
  • EP ID EP213095
  • DOI 10.22141/2224-0721.13.4.2017.106657
  • Views 73
  • Downloads 0

How To Cite

V. V. Semenko, V. M. Serdyuk, I. V. Savytskyi (2017). Development of experimental alloxan model of diabetes mellitus. Міжнародний ендокринологічний журнал, 13(4), 276-280. https://europub.co.uk./articles/-A-213095